148 related articles for article (PubMed ID: 15816107)
1. The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis.
Giralt J; de las Heras M; Cerezo L; Eraso A; Hermosilla E; Velez D; Lujan J; Espin E; Rosello J; Majó J; Benavente S; Armengol M; de Torres I;
Radiother Oncol; 2005 Feb; 74(2):101-8. PubMed ID: 15816107
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy.
Giralt J; Eraso A; Armengol M; Rosselló J; Majó J; Ares C; Espin E; Benavente S; de Torres I
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1460-5. PubMed ID: 12459370
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.
Azria D; Bibeau F; Barbier N; Zouhair A; Lemanski C; Rouanet P; Ychou M; Senesse P; Ozsahin M; Pèlegrin A; Dubois JB; Thèzenas S
BMC Cancer; 2005 Jun; 5():62. PubMed ID: 15967033
[TBL] [Abstract][Full Text] [Related]
4. Expression of epidermal growth factor receptor as a predictive factor for rectal cancer.
Motlagh A; Azadeh P; Fazlalizadeh A; Shahrad B; Shafaghi B; Fudazi M; Yosefi A; Davaei M
Arch Iran Med; 2007 Jul; 10(3):301-8. PubMed ID: 17604465
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
6. Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer.
Yasuda H; Tanaka K; Saigusa S; Toiyama Y; Koike Y; Okugawa Y; Yokoe T; Kawamoto A; Inoue Y; Miki C; Kusunoki M
Oncol Rep; 2009 Oct; 22(4):709-17. PubMed ID: 19724847
[TBL] [Abstract][Full Text] [Related]
7. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis.
Yao YF; Du CZ; Chen N; Chen P; Gu J
Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor as a predictor of tumor downstaging in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy.
Kim JS; Kim JM; Li S; Yoon WH; Song KS; Kim KH; Yeo SG; Nam JS; Cho MJ
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):195-200. PubMed ID: 16839708
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy.
Wu XY; Wu ZF; Cao QH; Chen C; Chen ZW; Xu Z; Li WS; Liu FK; Yao XQ; Li G
World J Gastroenterol; 2014 Nov; 20(43):16268-74. PubMed ID: 25473182
[TBL] [Abstract][Full Text] [Related]
10. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy.
Bouzourene H; Bosman FT; Seelentag W; Matter M; Coucke P
Cancer; 2002 Feb; 94(4):1121-30. PubMed ID: 11920483
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
12. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.
Moore HG; Shia J; Klimstra DS; Ruo L; Mazumdar M; Schwartz GK; Minsky BD; Saltz L; Guillem JG
Ann Surg Oncol; 2004 Nov; 11(11):955-61. PubMed ID: 15525823
[TBL] [Abstract][Full Text] [Related]
13. Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy.
Zlobec I; Vuong T; Compton CC; Lugli A; Michel RP; Hayashi S; Jass JR
Br J Cancer; 2008 Jan; 98(2):450-6. PubMed ID: 18182986
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor as a prognostic factor in locally advanced rectal-cancer patients treated with preoperative chemoradiation.
Li S; Kim JS; Kim JM; Cho MJ; Yoon WH; Song KS; Yeo SG; Kim JS
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):705-12. PubMed ID: 16690221
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Bengala C; Bettelli S; Bertolini F; Sartori G; Fontana A; Malavasi N; Depenni R; Zironi S; Del Giovane C; Luppi G; Conte PF
Br J Cancer; 2010 Sep; 103(7):1019-24. PubMed ID: 20842128
[TBL] [Abstract][Full Text] [Related]
16. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
[TBL] [Abstract][Full Text] [Related]
17. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy.
Peng YF; Yu WD; Pan HD; Wang L; Li M; Yao YF; Zhao J; Gu J
World J Gastroenterol; 2015 Feb; 21(6):1851-6. PubMed ID: 25684951
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 3-kinase CB association with preoperative radiotherapy response in rectal adenocarcinoma.
Yu WD; Peng YF; Pan HD; Wang L; Li K; Gu J
World J Gastroenterol; 2014 Nov; 20(43):16258-67. PubMed ID: 25473181
[TBL] [Abstract][Full Text] [Related]
19. P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma.
Cho NH; Kim YB; Park TK; Kim GE; Park K; Song KJ
Gynecol Oncol; 2003 Nov; 91(2):346-53. PubMed ID: 14599865
[TBL] [Abstract][Full Text] [Related]
20. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.
Theodoropoulos G; Wise WE; Padmanabhan A; Kerner BA; Taylor CW; Aguilar PS; Khanduja KS
Dis Colon Rectum; 2002 Jul; 45(7):895-903. PubMed ID: 12130878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]